PMC:7306567 / 2567-2712 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"50","span":{"begin":89,"end":111},"obj":"Disease"}],"attributes":[{"id":"A50","pred":"tao:has_database_id","subj":"50","obj":"MESH:D055744"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" the type and duration of immunosuppressive therapy [1]. Patients at the highest risk of invasive aspergillosis (IA) include those undergoing int"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T23","span":{"begin":89,"end":111},"obj":"Disease"},{"id":"T24","span":{"begin":98,"end":111},"obj":"Disease"},{"id":"T25","span":{"begin":113,"end":115},"obj":"Disease"}],"attributes":[{"id":"A23","pred":"mondo_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/MONDO_0000240"},{"id":"A24","pred":"mondo_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A25","pred":"mondo_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/MONDO_0000240"}],"text":" the type and duration of immunosuppressive therapy [1]. Patients at the highest risk of invasive aspergillosis (IA) include those undergoing int"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T6","span":{"begin":113,"end":115},"obj":"Chemical"}],"attributes":[{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_74062"}],"text":" the type and duration of immunosuppressive therapy [1]. Patients at the highest risk of invasive aspergillosis (IA) include those undergoing int"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T33","span":{"begin":26,"end":43},"obj":"CHEBI:35705;CHEBI:35705"},{"id":"T96288","span":{"begin":26,"end":43},"obj":"CHEBI:35705;CHEBI:35705"}],"text":" the type and duration of immunosuppressive therapy [1]. Patients at the highest risk of invasive aspergillosis (IA) include those undergoing int"}

{"project":"2_test","denotations":[{"id":"32572532-25354514-47963394","span":{"begin":53,"end":54},"obj":"25354514"},{"id":"T48775","span":{"begin":53,"end":54},"obj":"25354514"}],"text":" the type and duration of immunosuppressive therapy [1]. Patients at the highest risk of invasive aspergillosis (IA) include those undergoing int"}